Back to top
more

Fidelity Select Biotechnology: (MF: FBIOX)

(MF) As of Jun 22, 2017 06:05 PM ET

 Add to portfolio

$217.24 USD

+2.18 (1.01%)

Zacks MF Rank 2-Buy   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

View All Zacks Mutual Fund Rank #1's

Latest Performance as of May 31, 2017

Total Return %* Percentile Rank Objective
YTD 9.34 72
3 months -6.34 91
6 months 3.24 84
1 Year 3.21 79
3 Year 7.66 57
5 Year 19.44 27
10 Year 14.03 3

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 25.05
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 5/31/2017 8,551.73
%Turnover 5/31/2017 28.00

Risk

3 Year 5 Year 10 Year
Beta 54.44 70.09 2.70
Alpha 26.52 38.05 18.96
R Squared 0.02 0.02 0.02
Std. Dev. 29.33 26.92 23.97
Sharpe 0.42 0.88 2.00

Sector / Country Weightings

As of 5/31/2017 % of Portfolio
Health 74.59
Other 13.02
Services 11.93
Industrial Cyclical 0.34
Finance 0.08
Technology 0.04

Portfolio Holdings

Top Equity Holdings
(As of 2/28/2017)
% of Portfolio Value (Mil$)
AMGEN INC 9.87 944.46
ALEXION PHARMACEUTICALS I 5.92 567.16
CELGENE CORP 5.48 524.79
REGENERON PHARMACEUTICALS 4.71 450.88
BIOGEN INC 4.11 393.25
VERTEX PHARMACEUTICALS IN 2.69 257.79
INCYTE PHARMACEUTICALS IN 2.46 235.29
~TESARO INC 2.29 219.06
SEATTLE GENETICS INC 2.07 197.70

Stock Holding % of Net Assets

As Of 2/28/2017
Total Issues 209
Avg. P/E 32.73
Avg. P/Book 5.67
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 31,082

Allocation

% of Portfolio
Large Growth 18.19
Large Value 0.00
Small Growth 11.09
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00